French English

Background

Cécile Puech began her career in industrial property and joined Regimbeau in 2004, after obtaining her Ph.D in immunology.

Cécile supports her clients in defining a global intellectual property strategy, involving both the protection of their new innovations, the audit of already established internal or external portfolios, and the identification of potential obstacles to the exploitation of current or future projects and the definition of strategies to overcome these obstacles.

Cécile also assists her clients in the implementation of internal procedures that are essential to ensure the solidity of intellectual property assets and to maximize the value of each project.

On a technical level, Cécile has developed specific expertise in the field of immunotherapies, but also personalized medicine.

Cécile works with a variety of entities, including start-ups, SMEs, public entities, large groups, and investors, and makes sure to provide everyone with tailor-made support.

Qualifications

  • French Patent Attorney
  • European Patent Attorney

Education

  • Master’s in Engineering (Ecole Polytechnique)
  • Ph.D and MS in Immunology at the Pasteur Institute (Université Paris VI)
  • CEIPI Graduate (distinction in Patents)

Know-how

  • IP Audit
  • Acquisition of IP Rights & Strategy
  • IP Prosecution & Portfolio Management
  • Pre-litigation & Litigation
  • Freedom to operate

Teaching / Representative positions

  • Involved in the training of young professionals for the European Qualifying Examination (EPI-CEIPI)
  • Involved in the training of young professionals for the French Qualifying Examination (CNCPI Roundtables)

Award

  • Distinguished “Rising IP STARS” in 2018 and 2019 by Managing IP magazine​

Related news

Meetings - 24 Sep 2019

Bioproduction of Immunotherapies

Contribution by Cécile Puech on “Patent battles over antibody production (Upstream Processing) and territory constraints.” and participation of Gabrielle Faure-André at the 4th edition Bioproduction of Immunotherapies

By Gabrielle Faure-André, Ph.D and Cécile Puech, Ph.D
Meetings - 20 Jun 2019

Regimbeau IP ACADEMY 2019

Regimbeau is organising a 5-day training seminar on “European Patents and Designs: The Essentials” for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent…

By Jérôme Collin Nicolas Bouquin, Ph.D Isabelle Thill Anne Seibel Cécile Puech, Ph.D Martine Bloch-Weill Armelle Leonard Frédérique Durieux Guillaume Schwab Sylvain Thivillier Evelyne Roux Gabrielle Faure-André, Ph.D Yves de Saint-Pern and Caroline Huguet-Braun
Meetings - 16 May 2019

VivaTech

Participation of Anne-Laure Deleuze, Cécile Puech et Antoine Blin, at VivaTech.

By Anne-Laure Deleuze, Ph.D and Cécile Puech, Ph.D
Meetings - 05 Jul 2018

Awards ceremony of the iLab Competition

Participation of Cécile Puech, Anne Seibel et Philippe Bessiere in the awards ceremony of the iLab Competition organized by the Ministry of Higher Education and Research and BPI France on…

By Cécile Puech, Ph.D and Anne Seibel
Meetings - 05 Apr 2018

Regimbeau IP Academy 2018

Regimbeau is organising a 5-day training seminar on “European Patents and Designs: The Essentials” for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent…

By Jérôme Collin Sylvain Thivillier Isabelle Thill Frédérique Faivre Petit Evelyne Roux Emmanuelle Levy Martine Bloch-Weill Nicolas Bouquin, Ph.D Frédérique Durieux Caroline Huguet-Braun Cécile Puech, Ph.D Anne Seibel and Guillaume Schwab

Related publications

19 Oct 2022

Post-filing data and inventive step (case G2/21): the EPO’s Enlarged Board of Appeal gives its preliminary opinion

By Cécile Puech, Ph.D
19 Oct 2022

Protection of inventions relating to a dosage or administration regimen in China: possible but only in some cases

By Cécile Puech, Ph.D and Lazarina Choisnel
23 Dec 2021

Dosage or administration regimens are patentable in Japan, but inventive step may be tricky!

By Lazarina Choisnel and Cécile Puech, Ph.D
28 Oct 2021

Patentability of dosage requirements: towards an easing of requirements in canada

By Lazarina Choisnel and Cécile Puech, Ph.D
28 Oct 2021

Post-published evidence and inventive step: confirmed referral to the EPO’s Enlarged Board of Appeal (case G2/21)

By Cécile Puech, Ph.D
06 Oct 2021

Patentability of in vitro diagnostic methods in Canada: A favorable evolution!

By Armelle Leonard and Cécile Puech, Ph.D
05 Jul 2021

Antibodies defined by functional features: Beware of sufficiency of disclosure !

By Cécile Puech, Ph.D
19 Mar 2021

Patentability of Antibodies: The new version of European Guidelines finally contains a dedicated section!

By Cécile Puech, Ph.D
16 Jan 2019

What impact will a BREXIT without a withdrawal agreement as of March 30, 2019, have on your IP assets, in particular patents, trademarks & designs, domain names?

By Frédérique Faivre Petit Sylvain Thivillier Cécile Puech, Ph.D Evelyne Roux and Christian TEXIER